HeartBeam, Inc.

HeartBeam, Inc.

BEAT·NASDAQ

$1.47

+8.1%
HealthcareMedical - Healthcare Information Services

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

At a Glance

Live Snapshot
Market Cap$50.63M
EPS-0.6200
P/E Ratio-3.85
Earnings Date05/07/2026

beat

Total Non-Current Liabilities

Last Annual Value

0.00

3-Year CAGR

%

5-Year CAGR

%

10-Year CAGR

%

HeartBeam, Inc.

HeartBeam, Inc. Competitors Analysis of Total Non-Current Liabilities

BEAT · NASDAQ
CompanyTotal Non-Current Liabilities
CAGR 3Y
CAGR 5Y
CAGR 10Y
BEAT logo
HeartBeam, Inc.
NASDAQ:BEAT
0.00
N/AN/AN/A 
356.00K
-2.5%-48.7%N/A
419.00K
-48.0%-41.7%N/A
2.29M
-32.3%-14.9%51.3%
TELA logo
TELA Bio, Inc.
NASDAQ:TELA
57.13M
10.6%12.4%N/A
55.12M
14.9%17.7%N/A
MNOV logo
MediciNova, Inc.
NASDAQ:MNOV
218.92K
-29.0%-24.6%-24.5%
315.00K
N/AN/AN/A
15.44M
11.3%N/AN/A
8.44M
-42.4%-10.4%N/A
100.00K
0.0%-58.7%N/A
HeartBeam, Inc.

HeartBeam, Inc. Fair Value Envelope

BEAT · NASDAQ

Our analysis suggests that BEAT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.47, this represents a potential HIDDEN relative to our calculated worth for HeartBeam, Inc..

Intrinsic Value
Current Price: $1.47